Johnson & Johnson wins FDA nod for new intraocular lens
March 12, 2026
Johnson & Johnson (NYSE: JNJ)+ announced today that it received FDA approval for its Tecnis PureSee intraocular lens (IOL) for cataract surgery.
Johnson & Johnson (NYSE: JNJ)+ announced today that it received FDA approval for its Tecnis PureSee intraocular lens (IOL) for cataract surgery.
Procept BioRobotics (Nasdaq:PRCT) today announced the international rollout of its next-generation Hydros robotic system for Aquablation therapy.
An imaging test could safely halve the number of people who need a biopsy for suspected prostate cancer following inconclusive or reassuring results from an MRI scan, new research has found.
A study published in Nature Communications reveals a new way of measuring that editing process, known as splicing, directly. It is the first time scientists have been able to get a clear view of how tumors systematically rewire their genetic instructions to aid growth and survival, and it may point toward new ways of controlling the disease.
An AI-driven tool that tailors antidepressant treatment to individual patients was shown to improve outcomes for people with depression, compared to standard treatment, in a major international trial.
A research team from the Department of Pharmacology and Pharmacy at the LKS Faculty of Medicine of the University of Hong Kong (HKUMed) has developed an innovative AI-based cardiovascular risk prediction tool, called CardiOmicScore
Making a living brain transparent and watching its neurons fire without disturbing their function—sounds like science fiction, doesn’t it? Yet the solution may already exist within our own bodies. In a paper published in Nature Methods, a research team led by Kyushu University introduces a new reagent called SeeDB-Live.
A new preclinical study in mice shows that precancerous cells in the pancreas can be eliminated before they have the chance to become tumors.